✦ LIBER ✦
Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits
✍ Scribed by K. Y. Thong; R. E. J. Ryder; M. L. Cull; C. Walton; on behalf of the ABCD nationwide exenatide; liraglutide audit contributors (for list of contributors; see Supporting Information; Appendix S2)
- Book ID
- 115199923
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 125 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0742-3071
No coin nor oath required. For personal study only.